An Act Regarding Coverage For Step Therapy For Advanced Metastatic Cancer

LD 178 prohibits health insurance plans from requiring patients with advanced metastatic cancer or related symptoms (like severe side effects from cancer or treatment) to try and fail on other drugs before covering an FDA-approved treatment. It applies to health plans that cover these conditions and directly affects patients seeking timely access to necessary medications. The law ensures coverage for FDA-approved drugs that align with medical guidelines and evidence-based practice, eliminating a common step therapy barrier. This change removes delays in accessing approved treatments without altering insurance coverage requirements for other conditions.